Finding Savings With Cheap Prescriptions

Drugs sold as a cheaper alternative to brand named products are called buy generic drugs. Usually, generic drug companies cannot patent their active ingredients, but they can patent their own unique formulation.

The Food and Drug Administration of the United States of America governs all medications and according to them the generic drug is identical to the brand named drug, legally. Therefore, the same laws apply to generic drugs as their branded counterparts where strength, administration and safety are concerned. The cheapest prescriptions must contain the same active ingredient as the branded product and be within acceptable bioequivalent ranges.

Once the patent expires on a branded drug, generic drugs can be introduced into the market. This leads to competition on the market which brings down the price of both the generic and the branded drug.

American drug patents generally last 20 years, but manufacturers have to apply for the patent before starting with clinical trials. Hence, the active period of the patent is usually only about seven to twelve years.

Once a patent no longer protects a drug, generic drug companies can develop a similar product for a lot cheaper. This saves a lot of money for the generic company and enables them to market the product for a lot cheaper, hence the savings are passed onto health insurers and patients. Generic meds can be distributed within developing countries for a lot cheaper than the named brands.

Generic meds are imported to developing countries from countries such as India, which is the world’s leading developer of generic drugs. Manufacturers apply reverse engineering to the known drug formulations and then create generics that are the bioequivalent of the brand name’s drug. Generic medicine producers also save time and money since the brand name manufacturers have already proven the efficacy, as well as the safety of the drug during their clinical trials. Generic brands don’t have to undergo clinical trials.

Generic drug companies leverage off the marketing efforts of the brand name drug, which after a number of years on the market has become well-known to healthcare professionals.  These same professional can now easily switch over their patients from the branded product to the generic medication.

Branded products monopolize the industry while the patent applies and this allows them to price the product as they wish to maximize profits. In doing this, they produce funds to research and create additional drugs, which generic med companies lack the funds for.

It is legal for generic developers to create a new generic version when either the patent for the branded product expires, when they can certify the invalidity of the original patent or in a country where the patent is not valid. Not all patents are valid in all countries.

When a patent expires, the monopoly is removed.  Generally patents are not renewable. If the composition of a drug changes significantly in a new formulation, it will have to be patented again and new clinical trials will have to take place. If the original compound changes, the generic version with the original composition may still be sold unless it is taken off the market by regulators.

Developing countries import buy generic drugs to distribute in their countries at low cost; hence they are welcomed by healthcare professionals and patients alike.

Tags: , , , , , , , , ,

Leave a Reply